Laurus Labs Balance Sheet Health
Financial Health criteria checks 4/6
Laurus Labs has a total shareholder equity of ₹41.2B and total debt of ₹25.1B, which brings its debt-to-equity ratio to 60.9%. Its total assets and total liabilities are ₹83.9B and ₹42.7B respectively. Laurus Labs's EBIT is ₹4.2B making its interest coverage ratio 2.3. It has cash and short-term investments of ₹1.4B.
Key information
60.9%
Debt to equity ratio
₹25.07b
Debt
Interest coverage ratio | 2.3x |
Cash | ₹1.42b |
Equity | ₹41.16b |
Total liabilities | ₹42.71b |
Total assets | ₹83.87b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540222's short term assets (₹38.3B) exceed its short term liabilities (₹31.1B).
Long Term Liabilities: 540222's short term assets (₹38.3B) exceed its long term liabilities (₹11.6B).
Debt to Equity History and Analysis
Debt Level: 540222's net debt to equity ratio (57.5%) is considered high.
Reducing Debt: 540222's debt to equity ratio has reduced from 66.5% to 60.9% over the past 5 years.
Debt Coverage: 540222's debt is well covered by operating cash flow (26.6%).
Interest Coverage: 540222's interest payments on its debt are not well covered by EBIT (2.3x coverage).